✦ LIBER ✦

Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Assessing the Efficacy and Safety of Proton Pump Inhibitor Lansoprazole in Infants with Symptoms of Gastroesophageal Reflux Disease

✍ Scribed by Susan R. Orenstein; Eric Hassall; Wanda Furmaga-Jablonska; Stuart Atkinson; Marsha Raanan

Book ID: 113744977
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 517 KB
Volume: 154
Category: Article
ISSN: 1097-6833
DOI: 10.1016/j.jpeds.2008.09.054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisapride in the control of symptoms in

Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial

✍ Ralph C. Cohen; Edward V. O’Loughlin; Geoffrey P. Davidson; D.J. Moore; Diana M. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Lansoprazole for 24 weeks reduces asthma

Lansoprazole for 24 weeks reduces asthma exacerbations and improves quality of life in subjects with symptoms of acid reflux - a multicenter, randomized, double-blind, placebo controlled trial

✍ Michael R Littner; Felix W Leung; E.David Ballard II; Bidan Huang; Nina K Samra 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 25 KB

A randomized, double-blind, multicenter,

A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

✍ Hiroyoshi Ohta, Hiroshi Oka, Chie Usui, Masayuki Ohkura, Makoto Suzuki, Kusuki N 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 370 KB

Efficacy and safety of rebamipide for th

Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial

✍ Susumu Sugai; Hiroki Takahashi; Shuji Ohta; Makoto Nishinarita; Masami Takei; Sh 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 413 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place

A multicenter, randomized, double-blind,

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of a far infrared-emitting sericite belt in patients with primary dysmenorrhea

✍ Chae Hyeong Lee; Ju-Won Roh; Chi-Yeon Lim; Jin Hwa Hong; Jae Kwan Lee; Eung Gi M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 245 KB